How much funding has Neumora Therapeutics raised?

Neumora Therapeutics has raised $612.0M in total funding, most recently a Series B round.

Who are Neumora Therapeutics's investors?

Neumora Therapeutics's investors include ARCH Venture Partners, Altitude Life Science Ventures, Amgen, Polaris Partners, BVF Partners, Abu Dhabi Growth Fund.

When was Neumora Therapeutics founded?

Neumora Therapeutics was founded in 2021.

Where is Neumora Therapeutics headquartered?

Neumora Therapeutics is headquartered in Watertown, Massachusetts, United States.

What industry is Neumora Therapeutics in?

Neumora Therapeutics operates in Biotech, Drug Discovery, Healthcare, Therapeutics.

How many employees does Neumora Therapeutics have?

Neumora Therapeutics has 51-200 employees.

Neumora Therapeutics

formerly NeumoraIPO

Redefining neuroscience drug development.

Public · Watertown, United States · Founded 2021 · $612.0M raised

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2021
Business Model: B2B
Website: neumoratx.com

Total Funding: $612.0M
Last Round: $112.0M Series BOct 2022
Rounds: 2
Type: Public

About

Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company founded in 2021 to confront the global brain disease crisis through precision medicine. The company develops novel therapies targeting unproven mechanisms of action for neuropsychiatric and neurodegenerative disorders, pairing each drug candidate with a biomarker strategy to identify the right patients. Its pipeline includes treatments for depression, Alzheimer's agitation, and other CNS diseases.

Summary

Neumora Therapeutics is a Biotech company based in Watertown, United States, founded in 2021. It has raised $612.0M in total across 2 rounds, most recently a $112.0M Series B round in Oct 2022. Investors include ARCH Venture Partners, Altitude Life Science Ventures and Amgen.

LinkedIn X (Twitter)